<DOC>
	<DOCNO>NCT02118376</DOCNO>
	<brief_summary>GLP-1 receptor agonist promote fat redistribution obese woman type 2 diabetes , reduce liver fat content , improve inflammation state</brief_summary>
	<brief_title>Effects GLP-1 Receptor Agonist Fat Redistribution Inflammatory Status</brief_title>
	<detailed_description>As treatment type 2 diabetesGlucagon like peptide -1 ( Glucan-like peptide-1 , GLP-1 ) receptor agonist play role promote insulin secretion , inhibit glucagon secretionï¼Œand also central peripheral effect , inhibit appetite , reduce weight.GLP-1 receptor agonist promote fat redistribution obese woman type 2 diabetes , reduce liver fat content , improve inflammation state</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Clinical diagnosis overweight type 2 diabetes mellitus Poor body condition ( severe liver kidney dysfunction ) Unknown cause pancreatitis , chronic pancreatitis , pancreatic resection , stomach operation , malignant tumor , previous use systemic corticosteroid ( local inhalation exception ) heart function niacin , incomplete serious endocrine disease genetic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>obesity ; fat distribution ; inflammation</keyword>
</DOC>